Gyre Therapeutics (GYRE) P/E (2010 - 2026)
Gyre Therapeutics (GYRE) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Gyre Therapeutics (GYRE) P/E is -150.73. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Gyre Therapeutics (GYRE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -150.73 | -335.50% |
| 2025 | 64.00 | +10.75% |
| 2024 | 57.79 | -174.27% |
| 2023 | -77.81 | -469.85% |
| 2022 | 21.04 | -582.06% |
| 2021 | -4.36 | -88.03% |
| 2020 | -36.45 | +63.94% |
| 2019 | -22.24 | -52.74% |
| 2018 | -47.05 | +195.22% |
| 2017 | -15.94 | +300.83% |
| 2016 | -3.98 | -66.69% |
| 2015 | -11.93 | -87.31% |
| 2014 | -94.02 | -3.66% |
| 2013 | -97.59 | -34.67% |
| 2012 | -149.38 | -174.39% |
| 2011 | 200.81 | -73.55% |
| 2010 | 759.22 | N/A |
Comparison Gyre Therapeutics (GYRE) P/E with competitors
Gyre Therapeutics (GYRE) P/E is -150.73.